This procedure consists in blocking 100% of the production of Adrenaline from its source, and 20% of Noradrenaline from the adrenal marrow. Now the synthesis of Dopamine will have a new regulation; a new biochemical blueprint, and a new system of signals that causes for the shaking in Parkinson’s patients to disappear from the beginning, and the symptoms from schizophrenic patients to be eliminated.
This procedure was created by Ecuadorean Psychiatrist, Dr Jose Mackliff Hidalgo, after more than 30 years of research, and is now considered to be the most permanent solution to Parkinson and Schizophrenia available to date. The surgery consists of electrically burning the marrow in the narrow channel of the adrenal medullas which lie above the two kidneys in the body.
At the beginning of the decade of the 70’s, it was discovered that by increasing glucose, the aggressiveness in psychotic patients decreased. By 1974 Dr. Mackliff reviewed the results from a study by Hubell Von Vallet & Dell, in which the therapeutic effects of a drug called Clorpromazine on mental patients, were due precisely by inhibiting brain adrenaline.
By blocking the tissue in the suprarenal glands through the BEAM surgery, 100% of adrenaline, and 20% of noradrenaline, are also blocked in the blood stream and the symptoms in Parkinson and Schizophrenia disappear. Then in the brain, the glia and the hypothalamus detect the lack of these substances and their metabolisms are detected, and therefore, they take on the role of neuro-endocrine brain regulators, and start generating a new modal system, a new plasticity to the Tirosine chain; thus regulating the functions of Dopamine, Noradrenaline, and other neurotransmitters that communicate with these neurons. This way, Dopamine will be available in parts of the brain where it is only needed as in the “substantia nigra” in the case of Parkinson; and won’t be released in areas where it exists in excess, as in the “limbic zone” in the case of schizophrenia.
Why it Works
These were the results from the initial B.E.A.M surgeries done on dogs that had undergone drug-induced psychosis.
- It may be possible that hyperglycemia prevents the release of glucoregulation hormones . Hyperglycemia prevents the release of adrenaline (epinephrine).
- In this process, adrenaline is one of the most important hormones, because it is closely linked to the pathology of stress and monitoring of emotion. This is the only solution for the glucoregulation disorder and a new role system of H.P.A axis
- It is easy to deduce that if the final element of the biochemical chain of tyrosine (epinephrine) is blocked, then the whole chain changes the synthesis and delivery of Dopa, dopamine, and noradrenaline. The brain takes on the role of providing the noradrenaline needed for the production of dopa and dopamine.
- This means that if the role of epinephrine stops for eight hours of hyperglycemia with hypertonic solution, then this changes the blood homeostatic balance in the blood and brain and has an impact on the hypothalamic-pituitary-thyroid axis.
- On a biological level of analysis, much of the research has focused on the neuroendocrine system, particularly in the limbic-hypothalamic-pituitary-adrenal axis (LHPA).
Most Ecuadorian and foreign patients seeking operations are chronic, with more than ten years of schizophrenia or Parkinson and a long history of internment in the first. These patients with the help of antipsychotics and B.E.A.M have obtained a formidable elimination of positive and negative symptoms, as well as a better quality of life that is not possible with antipsychotics alone.
In Dr. Mackliff’s experience, patients with one to three years of schizophrenia (between 14 and 18) have a spectacular improvement in about 3-6 months after the operation. These cases correspond to 10% of the cases submitted to B.E.A.M, since most come to be operated when they are fully impaired, however they too obtain the elimination of symptoms.
Every case that has undergone B.E.A.M is unique and the patients live in homes with features and different environments which can impact positively or negatively on the operated patient.
It is interesting to note that the pharmaceutical industry spends billions $ on research on anti-depressant and antipsychotic drugs, and has virtually nothing to show for it. It has all been spent on useless studies designed to minimize the adverse effects of the drugs and the cerebral changes that result from their long term use.
Dr Mackliff has self-funded his entire research for 30 years and has now had over 110 successful surgeries on people with chronic schizophrenia since 2006. He presented his work and a case study of Sergio to the World – Neuro Talks in 2015 in Hangzhou, China with positive responses and results which may lead to formalizing the research into BEAM in the future. He is scheduled to present BEAM again at the 2018 World Congress Neurotalk conference with more case studies.